Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Medical Care Facilities

Max Healthcare Institute Limited provides medical and healthcare services in India. It offers services in various specialties, including advanced cardiac care, orthopaedics, oncology, renal sciences, neurosciences, minimal access metabolic and bariatric surgery, obstetrics, gynaecology, paediatrics, nephrology, and general surgery, as well as liver, heart, kidney, lung and bone marrow transplants. The company also provides Max@Home, a platform that offers health and wellness services at home; and MaxLab, which provides diagnostic services to patients outside its network of hospitals through various channels comprising third-party hospital laboratory management. It operates through a network of healthcare facilities, including hospitals and medical centres. The company was incorporated in 2001 and is based in Gurugram, India.

Revenue projections:

Revenue projections for MAXHEALTH
Revenue projections for MAXHEALTH

Max Healthcare Institute Limited is projected to see a decline in revenue compared to last year, which could lead to investor caution. A drop in earnings is often viewed as a negative signal for profitability, making it more difficult for the company to maintain investor confidence in its financial health.

Financial Ratios:

currentRatio 0.79300
forwardPE 44.23476
debtToEquity 32.57900
earningsGrowth 0.74300
revenueGrowth 0.25100
grossMargins 0.62122
operatingMargins 0.21871
trailingEps 13.88000
forwardEps 22.41224

With both earnings and revenue growth showing positive trends, MAXHEALTH is expected to expand its business. This signals a healthy financial trajectory, suggesting that the company is positioned for continued growth and increasing profitability.
MAXHEALTH's positive gross and operating margins indicate a profitable and efficient business model. These metrics highlight the company's ability to generate income while controlling operational costs, reflecting strong financial performance.
MAXHEALTH's forward EPS surpasses its trailing EPS, reflecting expectations of higher profitability in the current year. This suggests that MAXHEALTH is projected to generate stronger earnings, indicating an optimistic financial outlook compared to the prior year's results.

Price projections:

Price projections for MAXHEALTH
Price projections for MAXHEALTH

Price projections for MAXHEALTH have steadily increased, reflecting growing optimism about the company's future. This trend suggests that analysts believe MAXHEALTH is well-positioned for continued success.

Recommendation changes over time:

Recommendations trend for MAXHEALTH
Recommendations trend for MAXHEALTH


Analysts have shown a buy bias for Max Healthcare Institute Limited, signaling it as a strong investment choice. This positive outlook could motivate investors to allocate funds to Max Healthcare Institute Limited, seeing it as a reliable and potentially profitable option, especially in an environment where the stock market is highly scrutinized.